4:48 PM
Apr 04, 2017
 |  BC Extra  |  Clinical News

Researchers suggest ipgm-1 inhibitor could treat infections

Editor's Note: This article was updated on Apr 07, 2017 at 11:44 AM PDT

In a paper published Monday in Nature Communications, a team led by NIH and University of Tokyo researchers identified cyclic peptide inhibitors of the enzyme 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (ipgm-1) that could treat both parasitic and bacterial infections.

The authors said the enzyme is essential for survival in both parasites such as Brugia malayi, a roundworm which...

Read the full 272 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >